Tikun Olam-Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd TFSHF Peers
See (TFSHF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TFSHF | $1.50 | N/A | N/A | N/A | N/A | N/A |
| CLCGY | $42.66 | +1.38% | 20.22B | 31.84 | $1.34 | +0.09% |
| ALBBY | $14.00 | N/A | 11.26B | 63.64 | $0.22 | N/A |
| ALBHF | $0.67 | -0.61% | 10.71B | 66.59 | $0.01 | N/A |
| MSMKF | $19.70 | -12.21% | 7.95B | 21.65 | $0.91 | +1.34% |
| DCHPF | $46.90 | -0.21% | 5.34B | -151.29 | -$0.31 | N/A |
| RGEDF | $27.17 | +0.01% | 4.97B | 7.99 | $3.40 | N/A |
| GEDSF | $24.85 | +0.00% | 4.54B | 10.71 | $2.32 | +4.70% |
| RADLY | $2.60 | -1.52% | 4.52B | 20.00 | $0.13 | +0.41% |
| CSMYF | $46.06 | N/A | 3.65B | 19.77 | $2.33 | +0.89% |
Stock Comparison
TFSHF vs CLCGY Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, CLCGY has a market cap of 20.22B. Regarding current trading prices, TFSHF is priced at $1.50, while CLCGY trades at $42.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CLCGY's P/E ratio is 31.84. In terms of profitability, TFSHF's ROE is N/A, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, TFSHF is less volatile compared to CLCGY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs ALBBY Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, ALBBY has a market cap of 11.26B. Regarding current trading prices, TFSHF is priced at $1.50, while ALBBY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ALBBY's P/E ratio is 63.64. In terms of profitability, TFSHF's ROE is N/A, compared to ALBBY's ROE of +0.06%. Regarding short-term risk, TFSHF is less volatile compared to ALBBY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs ALBHF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, ALBHF has a market cap of 10.71B. Regarding current trading prices, TFSHF is priced at $1.50, while ALBHF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ALBHF's P/E ratio is 66.59. In terms of profitability, TFSHF's ROE is N/A, compared to ALBHF's ROE of +0.06%. Regarding short-term risk, TFSHF and ALBHF have similar daily volatility (0.00).
TFSHF vs MSMKF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, MSMKF has a market cap of 7.95B. Regarding current trading prices, TFSHF is priced at $1.50, while MSMKF trades at $19.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas MSMKF's P/E ratio is 21.65. In terms of profitability, TFSHF's ROE is N/A, compared to MSMKF's ROE of +0.07%. Regarding short-term risk, TFSHF is less volatile compared to MSMKF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs DCHPF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, DCHPF has a market cap of 5.34B. Regarding current trading prices, TFSHF is priced at $1.50, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, TFSHF's ROE is N/A, compared to DCHPF's ROE of N/A. Regarding short-term risk, TFSHF and DCHPF have similar daily volatility (0.00).
TFSHF vs RGEDF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, RGEDF has a market cap of 4.97B. Regarding current trading prices, TFSHF is priced at $1.50, while RGEDF trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RGEDF's P/E ratio is 7.99. In terms of profitability, TFSHF's ROE is N/A, compared to RGEDF's ROE of +0.20%. Regarding short-term risk, TFSHF is less volatile compared to RGEDF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs GEDSF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, GEDSF has a market cap of 4.54B. Regarding current trading prices, TFSHF is priced at $1.50, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, TFSHF's ROE is N/A, compared to GEDSF's ROE of +0.15%. Regarding short-term risk, TFSHF and GEDSF have similar daily volatility (0.00).
TFSHF vs RADLY Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, RADLY has a market cap of 4.52B. Regarding current trading prices, TFSHF is priced at $1.50, while RADLY trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RADLY's P/E ratio is 20.00. In terms of profitability, TFSHF's ROE is N/A, compared to RADLY's ROE of +0.18%. Regarding short-term risk, TFSHF is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs CSMYF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, CSMYF has a market cap of 3.65B. Regarding current trading prices, TFSHF is priced at $1.50, while CSMYF trades at $46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CSMYF's P/E ratio is 19.77. In terms of profitability, TFSHF's ROE is N/A, compared to CSMYF's ROE of +0.08%. Regarding short-term risk, TFSHF is less volatile compared to CSMYF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs WLCGF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, WLCGF has a market cap of 3.41B. Regarding current trading prices, TFSHF is priced at $1.50, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, TFSHF's ROE is N/A, compared to WLCGF's ROE of +0.09%. Regarding short-term risk, TFSHF and WLCGF have similar daily volatility (0.00).
TFSHF vs SDGCF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SDGCF has a market cap of 3.30B. Regarding current trading prices, TFSHF is priced at $1.50, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, TFSHF's ROE is N/A, compared to SDGCF's ROE of +0.05%. Regarding short-term risk, TFSHF and SDGCF have similar daily volatility (0.00).
TFSHF vs SAEYY Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SAEYY has a market cap of 3.01B. Regarding current trading prices, TFSHF is priced at $1.50, while SAEYY trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SAEYY's P/E ratio is -59.20. In terms of profitability, TFSHF's ROE is N/A, compared to SAEYY's ROE of -0.09%. Regarding short-term risk, TFSHF is less volatile compared to SAEYY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs SGIPF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SGIPF has a market cap of 2.95B. Regarding current trading prices, TFSHF is priced at $1.50, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, TFSHF's ROE is N/A, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, TFSHF and SGIPF have similar daily volatility (0.00).
TFSHF vs TSUSF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, TSUSF has a market cap of 2.68B. Regarding current trading prices, TFSHF is priced at $1.50, while TSUSF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas TSUSF's P/E ratio is 16.87. In terms of profitability, TFSHF's ROE is N/A, compared to TSUSF's ROE of +0.09%. Regarding short-term risk, TFSHF is less volatile compared to TSUSF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs SHPPF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SHPPF has a market cap of 2.61B. Regarding current trading prices, TFSHF is priced at $1.50, while SHPPF trades at $129.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SHPPF's P/E ratio is -91.49. In terms of profitability, TFSHF's ROE is N/A, compared to SHPPF's ROE of -0.09%. Regarding short-term risk, TFSHF is less volatile compared to SHPPF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs HTSUY Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, HTSUY has a market cap of 2.29B. Regarding current trading prices, TFSHF is priced at $1.50, while HTSUY trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HTSUY's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to HTSUY's ROE of +0.08%. Regarding short-term risk, TFSHF is less volatile compared to HTSUY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs BJTRF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, BJTRF has a market cap of 535.91M. Regarding current trading prices, TFSHF is priced at $1.50, while BJTRF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas BJTRF's P/E ratio is 8.00. In terms of profitability, TFSHF's ROE is N/A, compared to BJTRF's ROE of +0.03%. Regarding short-term risk, TFSHF and BJTRF have similar daily volatility (0.00).
TFSHF vs ZRSEF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, ZRSEF has a market cap of 499.65M. Regarding current trading prices, TFSHF is priced at $1.50, while ZRSEF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ZRSEF's P/E ratio is -2.14. In terms of profitability, TFSHF's ROE is N/A, compared to ZRSEF's ROE of -0.26%. Regarding short-term risk, TFSHF is less volatile compared to ZRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs NVACF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, NVACF has a market cap of 78.47M. Regarding current trading prices, TFSHF is priced at $1.50, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas NVACF's P/E ratio is 31.60. In terms of profitability, TFSHF's ROE is N/A, compared to NVACF's ROE of +0.06%. Regarding short-term risk, TFSHF is less volatile compared to NVACF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs KIARF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, KIARF has a market cap of 66.58M. Regarding current trading prices, TFSHF is priced at $1.50, while KIARF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas KIARF's P/E ratio is -0.01. In terms of profitability, TFSHF's ROE is N/A, compared to KIARF's ROE of -1.47%. Regarding short-term risk, TFSHF and KIARF have similar daily volatility (0.00).
TFSHF vs HTPRF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, HTPRF has a market cap of 11.86M. Regarding current trading prices, TFSHF is priced at $1.50, while HTPRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HTPRF's P/E ratio is -0.06. In terms of profitability, TFSHF's ROE is N/A, compared to HTPRF's ROE of +0.11%. Regarding short-term risk, TFSHF and HTPRF have similar daily volatility (0.00).
TFSHF vs ETBI Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, ETBI has a market cap of 9.03M. Regarding current trading prices, TFSHF is priced at $1.50, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ETBI's P/E ratio is -0.40. In terms of profitability, TFSHF's ROE is N/A, compared to ETBI's ROE of +0.00%. Regarding short-term risk, TFSHF is less volatile compared to ETBI. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs PNPL Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, PNPL has a market cap of 7.31M. Regarding current trading prices, TFSHF is priced at $1.50, while PNPL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas PNPL's P/E ratio is -10.00. In terms of profitability, TFSHF's ROE is N/A, compared to PNPL's ROE of +0.54%. Regarding short-term risk, TFSHF is less volatile compared to PNPL. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs FFLWF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, FFLWF has a market cap of 5.42M. Regarding current trading prices, TFSHF is priced at $1.50, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, TFSHF's ROE is N/A, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, TFSHF is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs RLLVF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, RLLVF has a market cap of 5.28M. Regarding current trading prices, TFSHF is priced at $1.50, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, TFSHF's ROE is N/A, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, TFSHF and RLLVF have similar daily volatility (0.00).
TFSHF vs HEWA Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, HEWA has a market cap of 4.26M. Regarding current trading prices, TFSHF is priced at $1.50, while HEWA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HEWA's P/E ratio is -3.33. In terms of profitability, TFSHF's ROE is N/A, compared to HEWA's ROE of +0.08%. Regarding short-term risk, TFSHF is less volatile compared to HEWA. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs LGNZZ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, LGNZZ has a market cap of 2.70M. Regarding current trading prices, TFSHF is priced at $1.50, while LGNZZ trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNZZ's ROE of -0.16%. Regarding short-term risk, TFSHF is less volatile compared to LGNZZ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs GABLF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, GABLF has a market cap of 2.66M. Regarding current trading prices, TFSHF is priced at $1.50, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas GABLF's P/E ratio is -0.04. In terms of profitability, TFSHF's ROE is N/A, compared to GABLF's ROE of +2.91%. Regarding short-term risk, TFSHF and GABLF have similar daily volatility (0.00).
TFSHF vs SYDRF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SYDRF has a market cap of 2.33M. Regarding current trading prices, TFSHF is priced at $1.50, while SYDRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SYDRF's P/E ratio is 8.00. In terms of profitability, TFSHF's ROE is N/A, compared to SYDRF's ROE of +0.96%. Regarding short-term risk, TFSHF is less volatile compared to SYDRF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs IWINF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, IWINF has a market cap of 1.68M. Regarding current trading prices, TFSHF is priced at $1.50, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IWINF's P/E ratio is -0.06. In terms of profitability, TFSHF's ROE is N/A, compared to IWINF's ROE of -0.77%. Regarding short-term risk, TFSHF and IWINF have similar daily volatility (0.00).
TFSHF vs NUTTQ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, NUTTQ has a market cap of 1.07M. Regarding current trading prices, TFSHF is priced at $1.50, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, TFSHF is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs LGNYZ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, LGNYZ has a market cap of 675297.00. Regarding current trading prices, TFSHF is priced at $1.50, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNYZ's ROE of -0.16%. Regarding short-term risk, TFSHF and LGNYZ have similar daily volatility (0.00).
TFSHF vs RADCQ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, RADCQ has a market cap of 559740.00. Regarding current trading prices, TFSHF is priced at $1.50, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, TFSHF's ROE is N/A, compared to RADCQ's ROE of +0.94%. Regarding short-term risk, TFSHF is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs AEGY Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, AEGY has a market cap of 411180.00. Regarding current trading prices, TFSHF is priced at $1.50, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas AEGY's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to AEGY's ROE of +0.00%. Regarding short-term risk, TFSHF is less volatile compared to AEGY. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs IPAH Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, IPAH has a market cap of 273628.00. Regarding current trading prices, TFSHF is priced at $1.50, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IPAH's P/E ratio is -0.05. In terms of profitability, TFSHF's ROE is N/A, compared to IPAH's ROE of -0.82%. Regarding short-term risk, TFSHF is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs FOGCF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, FOGCF has a market cap of 97176.00. Regarding current trading prices, TFSHF is priced at $1.50, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas FOGCF's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, TFSHF is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs MDIN Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, MDIN has a market cap of 90309.00. Regarding current trading prices, TFSHF is priced at $1.50, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas MDIN's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to MDIN's ROE of +0.36%. Regarding short-term risk, TFSHF is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs LGNDZ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, LGNDZ has a market cap of 73318.00. Regarding current trading prices, TFSHF is priced at $1.50, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNDZ's ROE of -0.16%. Regarding short-term risk, TFSHF is less volatile compared to LGNDZ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs OXIHF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, OXIHF has a market cap of 65725.00. Regarding current trading prices, TFSHF is priced at $1.50, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas OXIHF's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, TFSHF is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs HADV Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, HADV has a market cap of 64379.00. Regarding current trading prices, TFSHF is priced at $1.50, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HADV's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to HADV's ROE of +0.83%. Regarding short-term risk, TFSHF is less volatile compared to HADV. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs IMMB Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, IMMB has a market cap of 57497.00. Regarding current trading prices, TFSHF is priced at $1.50, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IMMB's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to IMMB's ROE of -0.09%. Regarding short-term risk, TFSHF and IMMB have similar daily volatility (0.00).
TFSHF vs DECN Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, DECN has a market cap of 35450.00. Regarding current trading prices, TFSHF is priced at $1.50, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas DECN's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to DECN's ROE of +0.00%. Regarding short-term risk, TFSHF and DECN have similar daily volatility (0.00).
TFSHF vs LGNXZ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, LGNXZ has a market cap of 35212.00. Regarding current trading prices, TFSHF is priced at $1.50, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to LGNXZ's ROE of -0.16%. Regarding short-term risk, TFSHF and LGNXZ have similar daily volatility (0.00).
TFSHF vs SPPH Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SPPH has a market cap of 29436.00. Regarding current trading prices, TFSHF is priced at $1.50, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SPPH's P/E ratio is -0.03. In terms of profitability, TFSHF's ROE is N/A, compared to SPPH's ROE of -0.50%. Regarding short-term risk, TFSHF is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs WPHM Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, WPHM has a market cap of 23223.00. Regarding current trading prices, TFSHF is priced at $1.50, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas WPHM's P/E ratio is -0.01. In terms of profitability, TFSHF's ROE is N/A, compared to WPHM's ROE of -1.56%. Regarding short-term risk, TFSHF is less volatile compared to WPHM. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs CAFS Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, CAFS has a market cap of 19883.00. Regarding current trading prices, TFSHF is priced at $1.50, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CAFS's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to CAFS's ROE of +1.94%. Regarding short-term risk, TFSHF and CAFS have similar daily volatility (0.00).
TFSHF vs SCRCQ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SCRCQ has a market cap of 14074.00. Regarding current trading prices, TFSHF is priced at $1.50, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, TFSHF's ROE is N/A, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, TFSHF is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs TSTS Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, TSTS has a market cap of 12754.00. Regarding current trading prices, TFSHF is priced at $1.50, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas TSTS's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to TSTS's ROE of +2.32%. Regarding short-term risk, TFSHF is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs IXSBF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, IXSBF has a market cap of 12627.00. Regarding current trading prices, TFSHF is priced at $1.50, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, TFSHF's ROE is N/A, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, TFSHF is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs VIAP Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, VIAP has a market cap of 10279.00. Regarding current trading prices, TFSHF is priced at $1.50, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas VIAP's P/E ratio is -0.05. In terms of profitability, TFSHF's ROE is N/A, compared to VIAP's ROE of +0.65%. Regarding short-term risk, TFSHF is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs OMHE Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, OMHE has a market cap of 9828.00. Regarding current trading prices, TFSHF is priced at $1.50, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas OMHE's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to OMHE's ROE of +0.73%. Regarding short-term risk, TFSHF is less volatile compared to OMHE. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs ALST Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, ALST has a market cap of 8449.00. Regarding current trading prices, TFSHF is priced at $1.50, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ALST's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to ALST's ROE of +0.13%. Regarding short-term risk, TFSHF is less volatile compared to ALST. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs HBOSF Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, HBOSF has a market cap of 7780.00. Regarding current trading prices, TFSHF is priced at $1.50, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, TFSHF's ROE is N/A, compared to HBOSF's ROE of +6.73%. Regarding short-term risk, TFSHF and HBOSF have similar daily volatility (0.00).
TFSHF vs PXYN Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, PXYN has a market cap of 6347.00. Regarding current trading prices, TFSHF is priced at $1.50, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas PXYN's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to PXYN's ROE of -0.20%. Regarding short-term risk, TFSHF is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs IYXI Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, IYXI has a market cap of 5311.00. Regarding current trading prices, TFSHF is priced at $1.50, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas IYXI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to IYXI's ROE of +1.71%. Regarding short-term risk, TFSHF and IYXI have similar daily volatility (0.00).
TFSHF vs CNBI Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, CNBI has a market cap of 3815.00. Regarding current trading prices, TFSHF is priced at $1.50, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas CNBI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to CNBI's ROE of +0.17%. Regarding short-term risk, TFSHF and CNBI have similar daily volatility (0.00).
TFSHF vs NEWG Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, NEWG has a market cap of 2260.00. Regarding current trading prices, TFSHF is priced at $1.50, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas NEWG's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to NEWG's ROE of +0.40%. Regarding short-term risk, TFSHF is less volatile compared to NEWG. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs FSPM Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, FSPM has a market cap of 1259.00. Regarding current trading prices, TFSHF is priced at $1.50, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas FSPM's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to FSPM's ROE of N/A. Regarding short-term risk, TFSHF and FSPM have similar daily volatility (0.00).
TFSHF vs GRPI Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, GRPI has a market cap of 1043.00. Regarding current trading prices, TFSHF is priced at $1.50, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas GRPI's P/E ratio is -0.02. In terms of profitability, TFSHF's ROE is N/A, compared to GRPI's ROE of +0.09%. Regarding short-term risk, TFSHF and GRPI have similar daily volatility (0.00).
TFSHF vs RBII Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, RBII has a market cap of 499.00. Regarding current trading prices, TFSHF is priced at $1.50, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas RBII's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to RBII's ROE of -0.04%. Regarding short-term risk, TFSHF and RBII have similar daily volatility (0.00).
TFSHF vs AXMP Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, AXMP has a market cap of 409.00. Regarding current trading prices, TFSHF is priced at $1.50, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas AXMP's P/E ratio is 0.00. In terms of profitability, TFSHF's ROE is N/A, compared to AXMP's ROE of N/A. Regarding short-term risk, TFSHF and AXMP have similar daily volatility (0.00).
TFSHF vs ACGJ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, ACGJ has a market cap of 324.00. Regarding current trading prices, TFSHF is priced at $1.50, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, TFSHF's ROE is N/A, compared to ACGJ's ROE of N/A. Regarding short-term risk, TFSHF and ACGJ have similar daily volatility (0.00).
TFSHF vs MDVLQ Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, MDVLQ has a market cap of 161.00. Regarding current trading prices, TFSHF is priced at $1.50, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, TFSHF and MDVLQ have similar daily volatility (0.00).
TFSHF vs ISHI Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, ISHI has a market cap of 5.00. Regarding current trading prices, TFSHF is priced at $1.50, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas ISHI's P/E ratio is N/A. In terms of profitability, TFSHF's ROE is N/A, compared to ISHI's ROE of N/A. Regarding short-term risk, TFSHF is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for TFSHF.
TFSHF vs SYNI Comparison
TFSHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFSHF stands at N/A. In comparison, SYNI has a market cap of 3.00. Regarding current trading prices, TFSHF is priced at $1.50, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFSHF currently has a P/E ratio of N/A, whereas SYNI's P/E ratio is -0.00. In terms of profitability, TFSHF's ROE is N/A, compared to SYNI's ROE of N/A. Regarding short-term risk, TFSHF and SYNI have similar daily volatility (0.00).